147 related articles for article (PubMed ID: 29417654)
1. Prevalence of adverse pathological features in 1 to 4 cm low-risk differentiated thyroid carcinoma.
Murthy SP; Balasubramanian D; Subramaniam N; Nair G; Babu MJC; Rathod PV; Thankappan K; Iyer S; Vijayan SN; Prasad C; Nair V
Head Neck; 2018 Jun; 40(6):1214-1218. PubMed ID: 29417654
[TBL] [Abstract][Full Text] [Related]
2. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.
Kluijfhout WP; Pasternak JD; Lim J; Kwon JS; Vriens MR; Clark OH; Shen WT; Gosnell JE; Suh I; Duh QY
Thyroid; 2016 Jun; 26(6):820-4. PubMed ID: 27083216
[TBL] [Abstract][Full Text] [Related]
3. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
[TBL] [Abstract][Full Text] [Related]
4. The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1-4 cm: implications for completion thyroidectomy following lobectomy.
Lang BH; Shek TW; Wan KY
Clin Endocrinol (Oxf); 2017 Feb; 86(2):236-242. PubMed ID: 27467318
[TBL] [Abstract][Full Text] [Related]
5. Reconsideration of tumor size threshold for total thyroidectomy in differentiated thyroid cancer.
Cheng SP; Chien MN; Wang TY; Lee JJ; Lee CC; Liu CL
Surgery; 2018 Sep; 164(3):504-510. PubMed ID: 29843911
[TBL] [Abstract][Full Text] [Related]
6. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
Kuo EJ; Thi WJ; Zheng F; Zanocco KA; Livhits MJ; Yeh MW
Thyroid; 2017 Dec; 27(12):1544-1549. PubMed ID: 29113553
[TBL] [Abstract][Full Text] [Related]
7. Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer.
Al-Qurayshi Z; Shama MA; Randolph GW; Kandil E
Endocr Relat Cancer; 2017 May; 24(5):221-226. PubMed ID: 28249964
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cm.
Lodewijk L; Kluijfhout WP; Kist JW; Stegeman I; Plukker JT; Nieveen van Dijkum EJ; Bonjer HJ; Bouvy ND; Schepers A; de Wilt JH; Netea-Maier RT; van der Hage JA; Burger JW; Ho G; Lee WS; Shen WT; Aronova A; Zarnegar R; Benay C; Mitmaker EJ; Sywak MS; Aniss AM; Kruijff S; James B; Grogan RH; Brunaud L; Hoch G; Pandolfi C; Ruan DT; Jones MD; Guerrero MA; Valk GD; Borel Rinkes IH; Vriens MR
Langenbecks Arch Surg; 2016 May; 401(3):365-73. PubMed ID: 27013326
[TBL] [Abstract][Full Text] [Related]
9. Thyroidectomy Practice After Implementation of the 2015 American Thyroid Association Guidelines on Surgical Options for Patients With Well-Differentiated Thyroid Carcinoma.
Hirshoren N; Kaganov K; Weinberger JM; Glaser B; Uziely B; Mizrahi I; Eliashar R; Mazeh H
JAMA Otolaryngol Head Neck Surg; 2018 May; 144(5):427-432. PubMed ID: 29596551
[TBL] [Abstract][Full Text] [Related]
10. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
11. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
[TBL] [Abstract][Full Text] [Related]
12. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
13. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
14. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study.
Kuba S; Yamanouchi K; Hayashida N; Maeda S; Adachi T; Sakimura C; Kawakami F; Yano H; Matsumoto M; Otsubo R; Sato S; Fujioka H; Kuroki T; Nagayasu T; Eguchi S
Int J Surg; 2017 Feb; 38():143-148. PubMed ID: 27677707
[TBL] [Abstract][Full Text] [Related]
15. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
[TBL] [Abstract][Full Text] [Related]
17. Thyroid lobectomy for low-risk thyroid cancers.
Puttergill B; Khan S; Christakis I; Dumbill R; Mclaren A; Sadler G; Mihai R
Ann R Coll Surg Engl; 2022 Feb; 104(2):113-116. PubMed ID: 35100851
[TBL] [Abstract][Full Text] [Related]
18. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
[TBL] [Abstract][Full Text] [Related]
19. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
Shaha AR
Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
[TBL] [Abstract][Full Text] [Related]
20. Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer.
Bakkar S; Al-Omar K; Donatini G; Aljarrah Q; Papavramidis TS; Materazzi G; Miccoli P
Endocrine; 2021 Dec; 74(3):611-615. PubMed ID: 34110601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
